careers
site map
About Us
Overview
Senior Management Team
Board of Directors
Product Portfolio
Marketed Products
Product Pipeline
Publications
Business Development
Contact
Fortress Companies
Aevitas Therapeutics
Avenue Therapeutics
Caelum Biosciences
Cellvation
Checkpoint Therapeutics
Cyprium Therapeutics
Helocyte, Inc
Journey Medical
Mustang Bio, Inc.
Tamid Bio, Inc.
Investors
Corporate Information
Corporate Profile
Senior Management
Board of Directors
Corporate Presentations
Press Releases
Events & Webcasts
Stock Information
Governance
Governance Documents
Committee Charting
SEC Filings
Documents
Section 16 Filings
Annual Meeting Materials
Other Information
Information Request
Email Notification
Contact Us
IN THE NEWS
April 18, 2018:
Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting
April 4, 2018:
Mustang Bio to Present at Biotech Innovations Conference
March 29, 2018:
Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights
March 28, 2018:
Avenue Therapeutics Receives Notices of Allowance for Patent Applications Covering Methods of Administration for Intravenous Tramadol
March 27, 2018:
Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis
QUICK LINKS
PIPELINE